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Abstract 
Dextran sulfate is semi-synthetic, polydisperse sulfated polysaccharide with important 
applications in clinical practice, in the manufacturing of plasma derived protein therapeutics 
and in biomedical research. The sensitive detection of dextran sulfate is relevant to 
preclinical and clinical drug development projects, the quality control of pharmaceutic 
formulations, and the process control in plasma fractionation using dextran sulfate modified 
chromatographic columns. Most analytical methods for the sensitive detection of dextran 
sulfate require multistep protcols and have not been transferred into commercial formats. We 
describe here the direct quantification of dextran sulfate using the commercially available 
molecular probe Heparin Red, by a simple mix-and-read fluorescence assay. With a 
sensitive benchtop fluorimeter, a quantification limit of 310 pg/mL dextran sulfate is achieved. 
This is superior by at least one order of magnitude to the quantification or detection limit of 
other reported methods. The outstanding simplicity and sensitivity establish Heparin Red as 
a new analytical tool for the determination of dextran sulfate. 
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Introduction 
Dextran sulfate structure and applications  
Dextran sulfate is semi-synthetic complex polysaccharide. It is prepared by chemical 
sulfation of dextran, a natural, polydisperse polysaccharide consisiting of a linear backbone 
of α(1,6) linked glucose monomers (scheme 1, left) that may have branches of smaller 
chains linked to the backbone by α(1,2), α(1,3) or α(1,4) glycosidic bonds.  
Dextran sulfate has important clinical applications. Dextran sulfate–cellulose columns are 
used as sorbents in blood purification therapies such as removal of low density lipoproteins 
(LDL apheresis) [1] to treat familial hypercholesterolemia, or of anti-DNA antibodies to treat 
systemic lupus erythematosus. Low molecular weight dextran sulfate (MW ≈5000 Dalton) has 
been granted orphan drug designation for mobilization of stem cells from the bone marrow 
prior to transplantation of hematopoetic stem cells, as well as for pancreatic islet cell 
transplantation [2]. In experimental nanomedicine, dextran sulfate is a key component of 
drug delivery systems [3,4]. Dextran sulfate suppresses the effect of amyloid beta on 
synaptic disfunction and was suggested as a candidate for treatment of Alzheimer’s disease 
[5]. High molecular weight dextran sulfate has inflammogenic properties and is commonly 
used to induce colitis in mouse models [6]. Dextran sulfate modified chromotagraphic 
columns are applied in plasma fractionation processes for the isolation of therapeutic plasma 
proteins, including Factor VIII, factor IX and  mannose-binding lectin [7].   
 
 
Methods for the quantification of dextran sulfate 
The sensitive detection of dextran sulfate is relevant to preclinical and clinical drug 
development projects, the quality control of pharmaceutic formulations, and the process 
control of plasma fractionation, to ensure that products are free of dextrane sulfate traces. 
Most of the assays described for the quantification of dextran sulfate (examples see table 1) 
require multistep protocols and/or challenging instrument calibration. Testing with the more 
recently developed resonance rayleigh scattering and potentiometric membrane methods is 
relatively simple, although in the latter the user has to prepare the potentiometric sensors for 
single use.   
 
 
 
 
 
 
 Quantification Method Matrix Detection limit 
(ng/mL) 
Ref. 
Competitive binding assay plasma 1000 [8] 
Size exclusion HPLC + postcolumn  
photometry (dimethyl methylene blue) serum 
300 [9] 
Resonance Rayleigh scattering 
of crystal violet complex 
buffer 13 a) 
 
[10] 
Strong ion exchange HPLC + postcolumn 
photometry (diemthyl methylene blue) 
protein 
solution 300 
[11] 
Potentiometric membrane electrode NaCl solution 760 [12] 
ELISA buffer 3 b) [13] 
 
 
Table 1. Methods for the quantification of dextran sulfate in different matrices, including detection 
limits.  a) Triple wavelength analysis; 27 ng/mL for single wavelength analysis.  .  b) Given by the 
provider as lower limit of measureable range for high molecular weight dextran sulfate.   
 
 
                   
Scheme 1. Left: Repeating 1,6-linked, trisulfated glucose moiety of dextran sulfate. Note that the 
sulfation degree of DS is variable; see table 1 for the sulfation degree of DS applied in this study. 
Right: Structure of the polycationic fluorescent probe Heparin Red (right).   
 
Quantification of sulfated polysaccharides with the fluorescent probe Heparin Red 
We describe here the application of the fluorescent probe “Heparin Red” to the determination 
of dextran sulfate. Heparin Red has been initially described as an experimental probe for 
heparin detection [14] and meanwhile developed further into commercially available assays 
[15] for the detection of sulfated polysaccharides in various matrices, including unfractioned 
and low-molecular weight heparins [16, 17], chemically modified heparins [16], heparan 
sulfate [18] and fucoidans [19]. Heparin Red is a polyamine derivative of a red-emissive 
perylene diimide fluorophore (scheme 1, right). It forms a supramolecular complex with the 
 
target, with aggregation of the probe molecules at the heparin template and contact 
quenching of fluorescence (scheme 2). The strong binding of the polycationic probe to 
polyanionic heparin appears to be controlled by both electrostatic and aromatic pi-stacking 
interactions [20]. 
 
Scheme 2. Schematic representation of fluorescence quenching of the molecular probe Heparin Red 
in the presence of dextran sulfate.     
 
In this contribution, we describe for the first time the application of the commercial reagent 
Heparin Red to the highly sensitive, direct quantification of dextran sulfate by a simple mix-
and-read cuvette assay.    
 
 
Materials and Methods 
Instrumentation 
Fluorescence measurements 
Fluorescence was measured with the benchtop fluorimeter FluoroLog®-3 (Horiba Scientific, 
Kyoto, Japan), excitation at 570 nm, emission recorded at 590-650 nm, integration time 0.4 
sec, average of 3 scans,  spectral band width Ex/Em 7nm.  
 
Pipettes  
Transferpette® 0,5-10µl, purchased from Brand GmbH, Wertheim. Rainin Pipettes 100-
1000µl, 20-200µl purchased from Mettler Toledo, OH, USA, Eppendorf Multipette M4, 50mL, 
purchased from VWR international, PA, USA.  
 
  
 
Reagents 
 
Heparin Red®  
Heparin Red® solution 100 µM, as a component of the Heparin Red® Kit, was a gift from 
Redprobes UG, Münster, Germany, www.redprobes.com . Product No HRU001, Lot 003.   
  
Dextran sulfate 
Dextran sulfate sodium salt, product number 42867, Lot # BCBP2520V, was purchased from 
Sigma Aldrich GmbH, Steinheim, Germany. Sulfur content 16,15% according to certificate of 
analysis. CHN analysis performed in our laboratory (average of two analyses): C 17,18 %, H 
3,54 % , N 1,55 %. N-content of the sample may arise from residual nitrogen-containg 
reagents (chlorosulfonic acid-pyridine or amidosulfonic acid), commonly used [21] for the 
chemical sulfation of dextran. No precipitate or cloudiness is observed after addition of 
Ba(NO3)2 to a 20 mg/mL solution of the dextran sulfate, indicating the absence of significant 
levels of free sulfate (SO42-).   
 
Other 
All aqueous solutions were prepared with HPLC grade water purchased from VWR, product 
No 23595.328. Dimethyl sulfoxide (DMSO), product number 34869, Lot # STBF6384V, and 
Hydrochloric acid (1,0 M), product number 35328, Lot # SZBF2050V, were purchased from 
Sigma Aldrich GmbH, Steinheim. 
 
Assays 
 
Heparin Red® Assay for dextran sulfate 
A 6,0 nM Heparin Red solution in DMSO containing 30 mM HCl was freshly prepared by 
mixing appropriate volumes of  DMSO, 1,0 M HCl and 100 µM Heparin Red solution. This 
mixture was stored at ambient temperature and used within 7 hours. Aqueous dextran sulfate 
solutions at 210 ng/mL (for titration and calibration curve) and 420 pg/mL (spiked sample) 
were freshly prepared  from a 2,1 mg/mL dextran sulfate stock solution and used within 2 
hours. 2,5 mL of the aqueous sample were placed in a 4,5 mL polystyrene fluorescence 
cuvette, 0,5 mL of the Heparin Red solution added, the cuvette sealed with a cap and briefly 
mixed by vortexing. The cuvette was then placed into the fluorimeter and fluorescence (590 – 
650 nm) recorded within 2 minutes (fluorescence of the mixture is stable for at least 20 
minutes). The calibration curve (figure 1) was derived by mixing 2,5 mL water and 0,5 mL 
 
Heparin Red solution as described above and titrating it with 5 µL aliquots of the 210 ng/mL 
dextran sulfate solution (vortexing after each addition).   
 
 
 
 
Results and discussion 
Detection of dextran sulfate in aqueous matrix 
Selected properties of the dextran sulfate sample applied in this study are listed in table 2.  
 Average mol. Weight a) Average sulfation (per 
monosaccharide) b) 
Average charge density 
(per monosachharide) 
Dextran 
sulfate 
40 kD 2,1 -2,1 
Table 2. Selected properties of the commercial dextran sulfate sodium salt used in this study. a) Taken 
from the certificate of analysis of the provider. b) Calculated using the ratio between S-content (16,15 
% according to certificate of analysis of the provider) and C-content (17,18 % by microanalysis in our 
laboratory) of the dextran sulfate sample. This approach for the sulfation degree implies that the 
sample is free of C- or S-containing impurities. 
A very sensitive benchtop fluorimeter was used for fluorescence measurements to ensure 
good signal-to-noise ratio at the low dye concentration applied. A 6,0 nM solution of Heparin 
Red in DMSO/30 mM HCl was prepared and applied to all determinations shown in figure 1. 
The calibration curve was derived by “titrating” a mixture of 0,5 mL of this Heparin Red 
solution and 2,5 mL water with dextran sulfate, leading to the expected quenching of dye 
fluorescence with increasing dextran sulfate concentration. A linear response is observed in 
the concentration range 0 – 2,1 ng/mL. Accurate recovery of a dextran sulfate spike was 
verified by mixing 2,5 mL of a 420 pg/mL aqueous solution with 0,5 mL Heparin Red solution. 
Fluorescence (F0) and standard deviation of the blank, i.e. an aqueous sample without 
dextran sulfate, was obtained by measuring mixtures of 2,5 mL water and 0,5 mL Heparin 
Red solution, each (n=6) in a different cuvette.    
  
Figure 1. Fluorescence response of Heparin Red to dextran sulfate. Excitation at 570 nm, 
fluorescence emission recorded at 612 nm. Solutions were allowed to equilibrate to ambient 
temperature (20°C) before mixing. Fluorescence corrected for the background value of pure water. F0 
is the average fluorescence of 6 blanks (CV = 0,7 %), i.e. mixtures of 2,5 mL water and 0,5 mL 
Heparin Red solution (6 nM in DMSO/30 mM HCl) in polystyerene cuvettes.  Calibration curve: 2,5 mL 
water and 0,5 mL Heparin Red solution (6 nM in DMSO/30 mM HCl) were mixed in a polystyrene 
cuvette and the mixture “titrated” with 5 µL aliquots of a 210 ng/mL dextran sulfate solution. This 
titration was performed twice in different cuvettes, average F/F0 values are given (CV averaged over 
all concentrations within linear range: 1,3 %). The indicated dextran sulfate concentration does not 
correspond to the actual concentration in the reaction mixture (3 mL) but is, for better comparison with 
the spike, related to the 2,5 mL aqueous portion. Spike: 2,5 mL aqueous dextran sulfate (420 pg/mL) 
and 0,5 mL Heparin Red solution (6 nM in DMSO/30 mM HCl) were mixed in a polystyrene cuvette; 
average of triplicate determination, CV = 2,7%.  
By extrapolation of the linear concentration range in figure 1, a theoretical intersection point 
with the fluorescence baseline at excess dextran sulfate is derived at 2,3 ng/mL dextran 
sulfate. This is somewhat higher than the calculated value 1,9 ng/mL for the formation of 
charge neutral, fluorescence-quenched aggregates with Heparin Red [20], considering the 
charge +8 for the fully protonated probe (scheme 1) and 5 pMol “negative charge” per ng 
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dextran sulfate, as derived from the S-content 16,15% of the dextran sulfate sample 
(assuming that each S atom contributes one –SO3- residue). The linear decrease of 
fluorescence indicates a smooth formation of the aggregate even at very low concentrations 
of the components. 
Quantification limit 
The quantification limit of the method (LOQ) was determined based on signal-to-noise [22], 
by comparing measured signals from samples with known low concentrations of analyte with 
those of blank samples. The LOQ was derived using the equation  
xQ = xതblank - 10 σblank 
where xQ, is the smallest measure that can be quantified with reasonable certainty for the 
given analytical procedure, xതblank is the mean of the blank measures, and σblank is the 
standard deviation of the blank measures. 
For the series of fluorescence measurements included in figure 1, xതblank = 1 and σblank = 
0,007 (n=6). A more representative value for σblank  is 0,012, obtained as an average of 4 
independent detections (n between 5 and 8), from which the highest σblank  was 0,015 . Using 
the latter value, xQ = 0,85 is calculated as the smallest quantitative fluorescence measure, 
what corresponds to a dextran sulfate LOQ = 310 pg/mL when compared with the linear 
range of the calibration curve. Recovery of a 420 pg/mL dextran sulfate spike with good 
precision (figure 1) confirms that pg/mL levels can indeed by quantified by the method. A 
refined analysis of spike recovery at the quantification and detection limit and the 
investigation of matrix effects in progress.   
  
Conclusion 
The sensitive quantification of dextran sulfate, a semi-synthetic sulfated polysaccharide, is 
relevant to clinical practice, the manufacturing of plasma derived protein therapeutics and to 
biomedical research. Current analytical methods often require multistep protocols and have 
quantification or detection limits in the ng/mL range. We describe here a simple mix-and-read 
fluorescence  assay for the determination of dextran sulfate with a quantification limit in the 
pg/mL range. The outstanding simplicity and sensitivity of the assay establish the fluorescent 
probe Heparin Red as a new tool for the quantification of dextran sulfate.   
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